Patients With Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible
RMD Open - United Kingdom
doi 10.1136/rmdopen-2019-000984
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Publisher
BMJ